Immunome, Inc.
NASDAQ:IMNM
8.84 (USD) • At close July 3, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 143.351 | 98.679 | 20.323 | 49.229 | 39.766 | 2.543 | 1.602 |
| Short Term Investments
| 73.952 | 39.463 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 217.303 | 138.142 | 20.323 | 49.229 | 39.766 | 2.543 | 1.602 |
| Net Receivables
| 0 | 0.289 | 0.847 | 4.312 | 0.85 | 0 | 0 |
| Inventory
| 0 | 0 | -0.847 | -4.312 | -0.9 | 0 | 0 |
| Other Current Assets
| 4.036 | 6.272 | 2.929 | 2.605 | 5.406 | 0.579 | 1.018 |
| Total Current Assets
| 221.339 | 144.703 | 22.649 | 56.638 | 42.894 | 3.122 | 2.111 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 14.391 | 3.637 | 0.965 | 0.855 | 1.531 | 1.7 | 2.082 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 4.511 | 0.1 | 0.332 | 0.332 | 0 | 0.138 | 0.155 |
| Total Non-Current Assets
| 18.902 | 3.837 | 1.397 | 1.287 | 1.631 | 1.938 | 2.337 |
| Total Assets
| 240.241 | 148.54 | 24.046 | 57.925 | 44.525 | 5.06 | 4.448 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 14.189 | 3.311 | 2.4 | 3.077 | 1.187 | 0.548 | 0.473 |
| Short Term Debt
| 0.063 | 0.31 | 0.229 | 0.317 | 0.479 | 0.451 | 0.612 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 6.941 | 10.493 | 0 | -0.317 | 0 | 0 | 0 |
| Other Current Liabilities
| 33.177 | 7.715 | 4.702 | 6.334 | 1.372 | 0.666 | 0.476 |
| Total Current Liabilities
| 54.307 | 21.829 | 7.331 | 9.728 | 3.038 | 1.665 | 1.561 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 9.538 | 1.34 | 0.062 | 0 | 0.134 | 0.113 | 0.564 |
| Deferred Revenue Non-Current
| 0 | 5.489 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0.012 | 0.008 | 38.912 | 27.528 |
| Total Non-Current Liabilities
| 4.769 | 6.829 | 0.062 | 0.012 | 0.142 | 39.025 | 28.092 |
| Total Liabilities
| 59.076 | 28.658 | 7.393 | 9.74 | 3.18 | 40.69 | 29.653 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 57.925 | 44.525 | 38.894 | 27.513 |
| Common Stock
| 0.006 | 0.004 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 |
| Retained Earnings
| -515.77 | -222.807 | -116.001 | -79.105 | -54.394 | -36.557 | -26.113 |
| Accumulated Other Comprehensive Income/Loss
| 0.057 | 0.022 | 0 | -57.925 | -44.525 | -38.895 | -0.904 |
| Other Total Stockholders Equity
| 696.872 | 342.663 | 132.653 | 69.364 | 95.738 | 39.822 | 1.811 |
| Total Shareholders Equity
| 181.165 | 119.882 | 16.653 | 48.185 | 41.345 | -35.63 | -25.205 |
| Total Equity
| 181.165 | 119.882 | 16.653 | 48.185 | 41.345 | -35.63 | -25.205 |
| Total Liabilities & Shareholders Equity
| 240.241 | 148.54 | 24.046 | 57.925 | 44.525 | 5.06 | 4.448 |